Guggenheim Capital LLC Gilead Sciences, Inc. Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 681,490 shares of GILD stock, worth $63.7 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
681,490
Previous 777,913 12.4%
Holding current value
$63.7 Million
Previous $53.4 Million 7.03%
% of portfolio
0.41%
Previous 0.38%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$66.59 - $83.99 $6.42 Million - $8.1 Million
-96,423 Reduced 12.4%
681,490 $57.1 Million
Q2 2024

Aug 14, 2024
BUY
$63.15 - $72.88 $5.18 Million - $5.98 Million
82,014 Added 11.79%
777,913 $53.4 Million
Q1 2024

May 14, 2024
SELL
$71.58 - $87.29 $4.62 Million - $5.63 Million
-64,504 Reduced 8.48%
695,899 $51 Million
Q4 2023

Feb 14, 2024
SELL
$73.27 - $83.09 $467,242 - $529,864
-6,377 Reduced 0.83%
760,403 $61.6 Million
Q3 2023

Nov 14, 2023
SELL
$73.94 - $80.67 $1.81 Million - $1.97 Million
-24,449 Reduced 3.09%
766,780 $57.5 Million
Q2 2023

Aug 11, 2023
BUY
$76.01 - $86.7 $1.47 Million - $1.68 Million
19,324 Added 2.5%
791,229 $61 Million
Q1 2023

May 10, 2023
SELL
$77.31 - $88.08 $2.44 Million - $2.78 Million
-31,537 Reduced 3.93%
771,905 $64 Million
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $2.81 Million - $4.03 Million
-45,064 Reduced 5.31%
803,442 $69 Million
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $2.16 Million - $2.47 Million
-36,335 Reduced 4.11%
848,506 $52.3 Million
Q2 2022

Aug 15, 2022
SELL
$57.72 - $65.01 $838,094 - $943,945
-14,520 Reduced 1.61%
884,841 $54.7 Million
Q1 2022

May 16, 2022
SELL
$57.92 - $72.58 $650,094 - $814,637
-11,224 Reduced 1.23%
899,361 $53.5 Million
Q4 2021

Feb 14, 2022
BUY
$64.88 - $73.64 $6.13 Million - $6.96 Million
94,509 Added 11.58%
910,585 $66.1 Million
Q3 2021

Nov 15, 2021
SELL
$67.69 - $73.03 $1.12 Million - $1.21 Million
-16,528 Reduced 1.99%
816,076 $57 Million
Q2 2021

Aug 13, 2021
BUY
$63.47 - $69.35 $2.16 Million - $2.36 Million
34,046 Added 4.26%
832,604 $57.3 Million
Q1 2021

May 13, 2021
SELL
$60.0 - $68.46 $709,800 - $809,881
-11,830 Reduced 1.46%
798,558 $51.6 Million
Q4 2020

Feb 16, 2021
BUY
$56.65 - $64.55 $785,735 - $895,308
13,870 Added 1.74%
810,388 $47.2 Million
Q3 2020

Nov 13, 2020
SELL
$62.1 - $78.08 $3.48 Million - $4.37 Million
-55,968 Reduced 6.57%
796,518 $50.3 Million
Q2 2020

Aug 14, 2020
BUY
$72.34 - $84.0 $6.04 Million - $7.01 Million
83,442 Added 10.85%
852,486 $65.6 Million
Q1 2020

Jun 02, 2020
SELL
$62.63 - $80.22 $9.33 Million - $11.9 Million
-148,927 Reduced 16.22%
769,044 $57.5 Million
Q4 2019

Feb 14, 2020
BUY
$61.62 - $67.78 $4.82 Million - $5.3 Million
78,152 Added 9.31%
917,971 $59.7 Million
Q3 2019

Nov 14, 2019
BUY
$62.51 - $69.0 $1.29 Million - $1.42 Million
20,618 Added 2.52%
839,819 $53.2 Million
Q2 2019

Aug 14, 2019
SELL
$61.87 - $69.38 $1.6 Million - $1.79 Million
-25,861 Reduced 3.06%
819,201 $55.3 Million
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $7.96 Million - $8.91 Million
127,220 Added 17.72%
845,062 $54.9 Million
Q4 2018

Feb 14, 2019
SELL
$60.54 - $79.0 $1.08 Million - $1.4 Million
-17,764 Reduced 2.41%
717,842 $44.9 Million
Q3 2018

Nov 14, 2018
SELL
$71.28 - $78.92 $3.51 Million - $3.89 Million
-49,280 Reduced 6.28%
735,606 $56.8 Million
Q2 2018

Aug 14, 2018
SELL
$64.88 - $75.68 $40 Million - $46.6 Million
-615,961 Reduced 43.97%
784,886 $55.6 Million
Q1 2018

May 15, 2018
SELL
$72.84 - $88.8 $7.11 Million - $8.66 Million
-97,546 Reduced 6.51%
1,400,847 $106 Million
Q4 2017

Feb 14, 2018
BUY
$71.15 - $83.52 $225,901 - $265,176
3,175 Added 0.21%
1,498,393 $107 Million
Q3 2017

Nov 14, 2017
BUY
$72.11 - $85.47 $108 Million - $128 Million
1,495,218
1,495,218 $121 Million

Others Institutions Holding GILD

# of Institutions
1,926
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email